CLINICAL TRIALS PROFILE FOR CYTOVENE

All Clinical Trials for Cytovene

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000134 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)	Completed	Baylor College of Medicine	Phase 3	1992-12-01	To compare the relative merits of three therapeutic regimens in patients with AIDS and CMV retinitis who have been previously treated but whose retinitis either is nonresponsive or has relapsed. These three therapeutic regimens were (1) foscarnet, (2) high-dose ganciclovir, and (3) combination foscarnet and ganciclovir. To compare two treatment strategies in patients with relapsed or nonresponsive CMV retinitis: (1) continuing the same anti-CMV drug or (2) switching to the alternate drug.
NCT00000134 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)	Completed	Icahn School of Medicine at Mount Sinai	Phase 3	1992-12-01	To compare the relative merits of three therapeutic regimens in patients with AIDS and CMV retinitis who have been previously treated but whose retinitis either is nonresponsive or has relapsed. These three therapeutic regimens were (1) foscarnet, (2) high-dose ganciclovir, and (3) combination foscarnet and ganciclovir. To compare two treatment strategies in patients with relapsed or nonresponsive CMV retinitis: (1) continuing the same anti-CMV drug or (2) switching to the alternate drug.
NCT00000134 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)	Completed	Johns Hopkins University	Phase 3	1992-12-01	To compare the relative merits of three therapeutic regimens in patients with AIDS and CMV retinitis who have been previously treated but whose retinitis either is nonresponsive or has relapsed. These three therapeutic regimens were (1) foscarnet, (2) high-dose ganciclovir, and (3) combination foscarnet and ganciclovir. To compare two treatment strategies in patients with relapsed or nonresponsive CMV retinitis: (1) continuing the same anti-CMV drug or (2) switching to the alternate drug.
NCT00000134 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)	Completed	Memorial Sloan Kettering Cancer Center	Phase 3	1992-12-01	To compare the relative merits of three therapeutic regimens in patients with AIDS and CMV retinitis who have been previously treated but whose retinitis either is nonresponsive or has relapsed. These three therapeutic regimens were (1) foscarnet, (2) high-dose ganciclovir, and (3) combination foscarnet and ganciclovir. To compare two treatment strategies in patients with relapsed or nonresponsive CMV retinitis: (1) continuing the same anti-CMV drug or (2) switching to the alternate drug.

Clinical Trial Conditions for Cytovene

Condition Name

Condition Name for Cytovene
Intervention	Trials
HIV Infections	5
Cytomegalovirus Retinitis	4
Myelodysplastic/Myeloproliferative Diseases	1
Kidney Diseases	1

Condition MeSH

Condition MeSH for Cytovene
Intervention	Trials
Retinitis	5
HIV Infections	5
Cytomegalovirus Retinitis	5
Leukemia	1

Clinical Trial Locations for Cytovene

Trials by Country

Trials by Country for Cytovene
Location	Trials
United States	36
Canada	1

Trials by US State

Trials by US State for Cytovene
Location	Trials
California	4
Pennsylvania	2
Missouri	2
Michigan	2
Massachusetts	2

Clinical Trial Progress for Cytovene

Clinical Trial Phase

Clinical Trial Phase for Cytovene
Clinical Trial Phase	Trials
Phase 3	3
Phase 2/Phase 3	2
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Cytovene
Clinical Trial Phase	Trials
Completed	8
Recruiting	1
Terminated	1

Clinical Trial Sponsors for Cytovene

Sponsor Name

Sponsor Name for Cytovene
Sponsor	Trials
Johns Hopkins Bloomberg School of Public Health	4
National Institute of Allergy and Infectious Diseases (NIAID)	3
Northwestern University	3

Sponsor Type

Sponsor Type for Cytovene
Sponsor	Trials
Other	49
NIH	8
Industry	4